Nicotinamide downregulates gene expression of interleukin-6, interleukin-10, monocyte chemoattractant protein-1, and tumour necrosis factor-α gene expression in HaCaT keratinocytes after ultraviolet B irradiation

Clinical and Experimental Dermatology

Volumn 38, Issue 2, 2013, Pages 185-188

  Monfrecola, G ^a   Gaudiello, F ^a   Cirillo, T ^a   Fabbrocini, G ^a   Balato, A ^a   Lembo, S ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 10; INTERLEUKIN 6; INTERLEUKIN 8; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; NICOTINAMIDE; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; GENE EXPRESSION REGULATION; INFLAMMATORY DISEASE; KERATINOCYTE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; ULTRAVIOLET B RADIATION;

CHEMOKINE CCL2; CYTOKINES; DOWN-REGULATION; GENE EXPRESSION PROFILING; HUMANS; INTERLEUKIN-10; INTERLEUKIN-6; KERATINOCYTES; NIACINAMIDE; REAL-TIME POLYMERASE CHAIN REACTION; RNA, MESSENGER; SKIN; TUMOR NECROSIS FACTOR-ALPHA; ULTRAVIOLET RAYS; VITAMIN B COMPLEX;

EID: 84873652500     PISSN: 03076938     EISSN: 13652230     Source Type: Journal    
DOI: 10.1111/ced.12018     Document Type: Article

References (10)

1. Virág L, Szabõ C,. The therapeutic potential of poly (ADP-ribose) polymerase inhibitors. Pharmacol Rev 2002; 54: 375-429.
2. Joohong P, Halliday G, Devita S, Damian D,. Nicotinamide prevents ultraviolet radiation-induced cellular energy loss. Photochem Photobiol 2010; 86: 942-8.
3. Ungerstedt JS, Blomback M, Soderstrom T,. Nicotinamide is a potent inhibitor of proinflammatory cytokines. Clin Exp Immunol 2003; 131: 48-52. (Pubitemid 36098821)
4. Grange P, Raingeaud J, Calvez V, Dupin V,. Nicotinamide inhibits Propionibacterium acnes-induced IL-8 production in keratinocytes through the NF-kB and MAPK pathways. J Dermatol Sci 2009; 56: 106-12.
5. Damian DL, Patterson CR, Stapelberg M, et al,. Ultraviolet radiation induced immunosuppression is greater in men and prevented by topical nicotinamide. J Invest Dermatol 2008; 128: 447-54.
6. Sivapirabu G, Yiasemides E, Halliday GM, et al,. Topical nicotinamide modulates cellular energy metabolism and provides broad-spectrum protection against ultraviolet radiation-induced immunosuppression in humans. Br J Dermatol 2009; 161: 1357-64.
7. Yoshizumi M, Nakamura T, Kato M, et al,. Release of cytokines/chemokines and cell death in UVB-irradiated human keratinocytes, HaCaT. Cell Biol Int 2008; 32: 1405-11.
8. Ahn KS, Moon KY, Lee J, Kim YS,. Downregulation of NF-kB activation in human keratinocytes by melanogenic inhibitors. J Dermatol Sci 2003; 31: 193-201. (Pubitemid 36519153)
9. Lukasova M, Hanson J, Tunaru S, Offermanns S,. Nicotinic acid (niacin): new lipid-independent mechanisms of action and therapeutic potentials. Trends Pharmacol Sci 2011; 32: 700-7.
10. Surjana D, Halliday GM, Martin AJ, et al,. Oral nicotinamide reduces actinic keratoses in phase II double-blinded randomized controlled trials. J Invest Dermatol 2012; 132: 1497-500.